Mitochondrial dysfunction in aging and Alzheimer's disease: Strategies to protect neurons
P (Hemachandra) Reddy
Recent structural and functional studies of mitochondria have revealed that abnormalities in mitochondria may lead to mitochondrial dysfunction in aged individuals and those with neurodegenerative diseases, including Alzheimer's disease (AD). Molecular, cellular, and biochemical studies of animal models of aging and AD have provided compelling evidence that mitochondria are involved in AD development and progression. Further, a role for mitochondrial dysfunction in AD is supported by studies of neurons from autopsy specimens of patients with AD, transgenic AD mice, and neuronal cells expressing human AD mutation, which have revealed that amyloid beta (Aβ) enters mitochondria early in the disease process and disrupts the electron-transport chain, generates reactive oxygen species, and inhibits the production of cellular ATP, which in turn prevents neurons from functioning normally. Although AD researchers are actively involved in understanding Aβ toxicity and trying to develop strategies to reduce Aβ toxicity, one route they have yet to take is to investigate the molecules that activate nonamyloidogenic α-secretase activity that may reduce Aβ production and toxicity. In addition, it may be worthwhile to develop mitochondrially targeted antioxidants to treat AD. This article discusses critical issues of mitochondria causing dysfunction in aging and AD and discusses the strategies to protect neurons caused by mitochondrial dysfunction.
Antioxidants and Redox Signaling
https://doi.org/10.1089/ars.2007.1754
Amyloid Precursor Protein Secretases
Reddy, P. H. (2007). Mitochondrial dysfunction in aging and Alzheimer's disease: Strategies to protect neurons. Antioxidants and Redox Signaling, 9(10), 1647-1658. https://doi.org/10.1089/ars.2007.1754
Mitochondrial dysfunction in aging and Alzheimer's disease : Strategies to protect neurons. / Reddy, P (Hemachandra).
In: Antioxidants and Redox Signaling, Vol. 9, No. 10, 10.2007, p. 1647-1658.
Reddy, PH 2007, 'Mitochondrial dysfunction in aging and Alzheimer's disease: Strategies to protect neurons', Antioxidants and Redox Signaling, vol. 9, no. 10, pp. 1647-1658. https://doi.org/10.1089/ars.2007.1754
Reddy PH. Mitochondrial dysfunction in aging and Alzheimer's disease: Strategies to protect neurons. Antioxidants and Redox Signaling. 2007 Oct;9(10):1647-1658. https://doi.org/10.1089/ars.2007.1754
Reddy, P (Hemachandra). / Mitochondrial dysfunction in aging and Alzheimer's disease : Strategies to protect neurons. In: Antioxidants and Redox Signaling. 2007 ; Vol. 9, No. 10. pp. 1647-1658.
@article{1d98ada4e836460f99ec8fbfdaa76156,
title = "Mitochondrial dysfunction in aging and Alzheimer's disease: Strategies to protect neurons",
abstract = "Recent structural and functional studies of mitochondria have revealed that abnormalities in mitochondria may lead to mitochondrial dysfunction in aged individuals and those with neurodegenerative diseases, including Alzheimer's disease (AD). Molecular, cellular, and biochemical studies of animal models of aging and AD have provided compelling evidence that mitochondria are involved in AD development and progression. Further, a role for mitochondrial dysfunction in AD is supported by studies of neurons from autopsy specimens of patients with AD, transgenic AD mice, and neuronal cells expressing human AD mutation, which have revealed that amyloid beta (Aβ) enters mitochondria early in the disease process and disrupts the electron-transport chain, generates reactive oxygen species, and inhibits the production of cellular ATP, which in turn prevents neurons from functioning normally. Although AD researchers are actively involved in understanding Aβ toxicity and trying to develop strategies to reduce Aβ toxicity, one route they have yet to take is to investigate the molecules that activate nonamyloidogenic α-secretase activity that may reduce Aβ production and toxicity. In addition, it may be worthwhile to develop mitochondrially targeted antioxidants to treat AD. This article discusses critical issues of mitochondria causing dysfunction in aging and AD and discusses the strategies to protect neurons caused by mitochondrial dysfunction.",
author = "Reddy, {P (Hemachandra)}",
doi = "10.1089/ars.2007.1754",
journal = "Antioxidants and Redox Signaling",
T1 - Mitochondrial dysfunction in aging and Alzheimer's disease
T2 - Strategies to protect neurons
AU - Reddy, P (Hemachandra)
N2 - Recent structural and functional studies of mitochondria have revealed that abnormalities in mitochondria may lead to mitochondrial dysfunction in aged individuals and those with neurodegenerative diseases, including Alzheimer's disease (AD). Molecular, cellular, and biochemical studies of animal models of aging and AD have provided compelling evidence that mitochondria are involved in AD development and progression. Further, a role for mitochondrial dysfunction in AD is supported by studies of neurons from autopsy specimens of patients with AD, transgenic AD mice, and neuronal cells expressing human AD mutation, which have revealed that amyloid beta (Aβ) enters mitochondria early in the disease process and disrupts the electron-transport chain, generates reactive oxygen species, and inhibits the production of cellular ATP, which in turn prevents neurons from functioning normally. Although AD researchers are actively involved in understanding Aβ toxicity and trying to develop strategies to reduce Aβ toxicity, one route they have yet to take is to investigate the molecules that activate nonamyloidogenic α-secretase activity that may reduce Aβ production and toxicity. In addition, it may be worthwhile to develop mitochondrially targeted antioxidants to treat AD. This article discusses critical issues of mitochondria causing dysfunction in aging and AD and discusses the strategies to protect neurons caused by mitochondrial dysfunction.
AB - Recent structural and functional studies of mitochondria have revealed that abnormalities in mitochondria may lead to mitochondrial dysfunction in aged individuals and those with neurodegenerative diseases, including Alzheimer's disease (AD). Molecular, cellular, and biochemical studies of animal models of aging and AD have provided compelling evidence that mitochondria are involved in AD development and progression. Further, a role for mitochondrial dysfunction in AD is supported by studies of neurons from autopsy specimens of patients with AD, transgenic AD mice, and neuronal cells expressing human AD mutation, which have revealed that amyloid beta (Aβ) enters mitochondria early in the disease process and disrupts the electron-transport chain, generates reactive oxygen species, and inhibits the production of cellular ATP, which in turn prevents neurons from functioning normally. Although AD researchers are actively involved in understanding Aβ toxicity and trying to develop strategies to reduce Aβ toxicity, one route they have yet to take is to investigate the molecules that activate nonamyloidogenic α-secretase activity that may reduce Aβ production and toxicity. In addition, it may be worthwhile to develop mitochondrially targeted antioxidants to treat AD. This article discusses critical issues of mitochondria causing dysfunction in aging and AD and discusses the strategies to protect neurons caused by mitochondrial dysfunction.
U2 - 10.1089/ars.2007.1754
DO - 10.1089/ars.2007.1754
JO - Antioxidants and Redox Signaling
JF - Antioxidants and Redox Signaling
10.1089/ars.2007.1754